Trial Details
COMPLETEDBasic Information
| Clinical ID | c1458 |
|---|---|
| Identifier | NCT02368717 |
| Trial Title | An Efficacy and Safety Study of PENTASA in Chinese Patients With Left-sided Active Ulcerative Colitis Followed by a 24-Week Open-Label Extension Phase |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Mesalazine Enema|DRUG: Placebo Enema |
Participant Information
| Sponsor | Ferring Pharmaceuticals |
|---|---|
| City | Guangzhou |
| Country/Region | China |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2025-03-15 |
|---|---|
| Primary Completion Date | 2017-01-05 |
| Completion Date | 2017-07-25 |